ANA MARIA PITA LOTTENBERG
Projetos de Pesquisa
Unidades Organizacionais
LIM/10 - Laboratório de Lípides, Hospital das Clínicas, Faculdade de Medicina
3 resultados
Resultados de Busca
Agora exibindo 1 - 3 de 3
- Position statement on nutrition therapy for overweight and obesity: nutrition department of the Brazilian association for the study of obesity and metabolic syndrome (ABESO-2022)(2023) PEPE, Renata Bressan; LOTTENBERG, Ana Maria; FUJIWARA, Clarissa Tamie Hiwatashi; BEYRUTI, Monica; CINTRA, Dennys Esper; MACHADO, Roberta Marcondes; RODRIGUES, Alessandra; JENSEN, Natalia Sanchez Oliveira; CALDAS, Ana Paula Silva; FERNANDES, Ariana Ester; ROSSONI, Carina; MATTOS, Fernanda; MOTARELLI, Joao Henrique Fabiano; BRESSAN, Josefina; SALDANHA, Juliana; BEDA, Lis Mie Masuzawa; LAVRADOR, Maria Silvia Ferrari; BOSCO, Mariana Del; CRUZ, Patricia; CORREIA, Poliana Espindola; MAXIMINO, Priscila; PEREIRA, Silvia; FARIA, Silvia Leite; PIOVACARI, Silvia Maria FragaObesity is a chronic disease resulting from multifactorial causes mainly related to lifestyle (sedentary lifestyle, inadequate eating habits) and to other conditions such as genetic, hereditary, psychological, cultural, and ethnic factors. The weight loss process is slow and complex, and involves lifestyle changes with an emphasis on nutritional therapy, physical activity practice, psychological interventions, and pharmacological or surgical treatment. Because the management of obesity is a long-term process, it is essential that the nutritional treatment contributes to the maintenance of the individual's global health. The main diet-related causes associated with excess weight are the high consumption of ultraprocessed foods, which are high in fats, sugars, and have high energy density; increased portion sizes; and low intake of fruits, vegetables, and grains. In addition, some situations negatively interfere with the weight loss process, such as fad diets that involve the belief in superfoods, the use of teas and phytotherapics, or even the avoidance of certain food groups, as has currently been the case for foods that are sources of carbohydrates. Individuals with obesity are often exposed to fad diets and, on a recurring basis, adhere to proposals with promises of quick solutions, which are not supported by the scientific literature. The adoption of a dietary pattern combining foods such as grains, lean meats, low-fat dairy, fruits, and vegetables, associated with an energy deficit, is the nutritional treatment recommended by the main international guidelines. Moreover, an emphasis on behavioral aspects including motivational interviewing and the encouragement for the individual to develop skills will contribute to achieve and maintain a healthy weight. Therefore, this Position Statement was prepared based on the analysis of the main randomized controlled studies and meta-analyses that tested different nutrition interventions for weight loss. Topics in the frontier of knowledge such as gut microbiota, inflammation, and nutritional genomics, as well as the processes involved in weight regain, were included in this document. This Position Statement was prepared by the Nutrition Department of the Brazilian Association for the Study of Obesity and Metabolic Syndrome (ABESO), with the collaboration of dietitians from research and clinical fields with an emphasis on strategies for weight loss.
- Brazilian Position Statement for Familial Chylomicronemia Syndrome-2023(2023) IZAR, Maria Cristina de Oliveira; SANTOS FILHO, Raul Dias dos; ASSAD, Marcelo Heitor Vieira; CHAGAS, Antonio Carlos Palandri; TOLEDO JUNIOR, Alceu de Oliveira; NOGUEIRA, Ana Claudia Cavalcante; SOUTO, Ana Cristina Carneiro Fernandes; LOTTENBERG, Ana Maria Pitta; CHACRA, Ana Paula Marte; FERREIRA, Carlos Eduardo dos Santos; LOURENCO, Charles Marques; VALERIO, Cynthia Melissa; CINTRA, Dennys Esper; FONSECA, Francisco Antonio Helfenstein; CAMPANA, Gustavo Aguiar; BIANCO, Henrique Tria; LIMA, Josivan Gomes de; CASTELO, Maria Helane Costa Gurgel; SCARTEZINI, Marileia; MORETTI, Miguel Antonio; BARRETO, Natasha Slhessarenko Fraife; MAIA, Rayana Elias; MONTENEGRO JUNIOR, Renan Magalhaes; ALVES, Renato Jorge; FIGUEIREDO, Roberta Marcondes Machado; FOCK, Rodrigo Ambrosio; MARTINEZ, Tania Leme da Rocha(iii) any legal person in which any of these is either a direct or indirect controlling owner, business partner, shareholder or advisory boards, investigative boards or other committees, etc. From the brazilian or international pharmaceutical, orthosis, Funding of continuing medical education activities, including travel, accommodation and registration in conferences and Any economically relevant equity interest in companies in the healthcare or education industry or in any companies competing
- Brazilian evidence-based guideline for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in adult individuals with overweight or obesity: A joint position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Hepatology (SBH), and Brazilian Association for the Study of Obesity and Metabolic Syndrome (Abeso)(2023) MOREIRA, Rodrigo Oliveira; VALERIO, Cynthia Melissa; VILLELA-NOGUEIRA, Cristiane Alves; CERCATO, Cintia; GERCHMAN, Fernando; LOTTENBERG, Ana Maria Pita; GODOY-MATAS, Amelio Fernando; OLIVEIRA, Ricardo de Andrade; MELLO, Carlos Eduardo Brandao; ALVARES-DA-SILVA, Mario Reis; LEITE, Nathalie Carvalho; COTRIM, Helma Pinchemel; PARISI, Edison Roberto; SILVA, Giovanni Faria; MIRANDA, Paulo Augusto Carvalho; HALPERN, Bruno; OLIVEIRA, Claudia PintoIntroduction: Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as Nonalcoholic fatty liver disease (NAFLD), is one of the most common hepatic diseases in individuals with overweight or obesity. In this context, a panel of experts from three medical societies was organized to develop an evidence-based guideline on the screening, diagnosis, treatment, and follow-up of MASLD. Material and methods: A MEDLINE search was performed to identify randomized clinical trials, meta-analyses, cohort studies, observational studies, and other relevant studies on NAFLD. In the absence of studies on a certain topic or when the quality of the study was not adequate, the opinion of experts was adopted. Classes of Recommendation and Levels of Evidence were determined using prespecified criteria. Results: Based on the literature review, 48 specific recommendations were elaborated, including 11 on screening and diagnosis, 9 on follow-up, 14 on nonpharmacologic treatment, and 14 on pharmacologic and surgical treatment. Conclusions: A literature search allowed the development of evidence-based guidelines on the screening, diagnosis, treatment, and follow-up of MASLD in individuals with overweight or obesity.